FDA Investigator Sinai I Davis
Sinai I Davis has conducted inspections on 97 sites in 1 countries as of 07 Nov 2006. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
97
Last Inspection Date:
07 Nov 2006
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sinai I Davis:
Addam S Reynolds,
Alberto A Viciedo,
Alexandra A Carrico,
Allen Lou,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Ankur C Patel,
Ann Marie Montemurro,
Annemarie B Randow,
Annemarie Bodnar,
Anthony J Donato,
Anthony M Criscuolo, Jr,
Anthony R Rauert,
Atul J Agrawal,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Benjamin Bustamante,
Brandi L Garbutt,
Byungja E Marciante,
Cara M Minelli,
Cary Greene,
Charles J Chacko,
Charlotte P Chang,
Cheryl J Legrand,
Christian Parra,
Christina N Maurino,
Christine M Cerenzio,
Craig W Swanson,
Daniel J Grabicki,
David H Smith,
Dawn L Wydner,
Deborah B Nixon,
Denise M Visco, Investigator,
Dennis E Guilfoyle, PhD,
Dhaval H Patel,
Diane M Gubernot,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Dung N Tran,
Edward O'shaughnessy,
Emest F Bizjak,
Emily A Walters,
Emmanuel Jramos Maldonado,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Eufemia G Gonzalez,
Frank J Marciniak,
Frederick F Razzaghi,
George Pyramides,
Gianine E Delade,
Gianine E Tompkins,
Gillian B Nardelli,
Guerlain Ulysse,
Haitao Li,
Helen B Ricalde,
Helen Verdel,
Jacqueline Mdiaz Albertini,
Janet A Rajan,
Jason M Sluzynski,
Jay T Wong,
Jean M Kelahan,
Jeffrey J Ebersole,
Jennifer A Bazergui,
Jennifer Macmillan,
Jessica M Monteiro,
Johnna L Bleem,
Jonathan Ho,
Jonee J Mearns,
Jose M Cayuela,
Joseph F Mcginnis, RPh,
Josh Renzo N Ramilo,
Joy F Canlas,
Joy Rkozlowski Klena,
Juanita P Versace,
Justin H Price,
Justine Tomasso,
Karen E D'orazio,
Karen F Tomaziefski,
Keith M Reilly,
Kelli F Dobilas,
Kelli Regente,
Kelly Doremus,
Kelly I Anderson,
Kerry A Kurdilla,
Kevin N Tran,
Kevin Obrien,
Kinh Q Mac,
Krishnaiah Yellela,
Kristina L Conroy,
Kristy A Zielny,
Krystal O Ogunremi,
Kwong P Lee,
Laishan L Lam,
Larry Johnson,
Lata C Mathew, PhD,
Lawrence R Johnson,
Lcr Jayt Wong,
Li Li,
Liatte Kreuger, PharmD,
Lisa Harlan,
Lisa Mathew,
Loretta Nemchik,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Maria Estrella,
Maria Manzoni, PhD,
Marie T Falcone,
Marjorie D Schultz,
Melba Trivera Clavell,
Melissa B Libby,
Melissa T Roy,
Meredith L Sheridan,
Merril E Racke,
Meyer J Slobotsky,
Michael R Klapal,
Michael Serrano,
Miguel Gmanzano Maldonado,
Monika Borkowska,
Naakesh N Gomanie,
Nancy F Scheraga,
Nancy L Rolli,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Nikki S Ramirez,
Nina Yang,
Niraj R Mehta, PhD,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Remache,
Richard D Manney,
Robert D Tollefsen,
Robert G Ruff,
Robert Sharpnack,
Rodrigo Vilchez,
Sachinkumar V Patel,
Sandra Kershaw,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Shahla Parvizi,
Sherri J Liu,
Shirley H Isbill,
Sidney B Priesmeyer,
Stephanie T Durso,
Stephen J Mottola,
Stephenie M Ortiz,
Steven P Donald,
Suchan Kim,
Susan M Halsted,
Tania E Garcia,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Thomas N Adjabeng,
Tonia F Bernard,
Tressa T Lewis,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William R Chang,
Xiaohan Cai, PhD,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu
Sinai I Davis's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2002 | FDA 483 | EBI, LLC - Form 483, 2002-11-07 |
| August, 2001 | EIR | LTS Lohmann Therapy Systems Corp. - EIR, 2001-08-09 |
| June, 2003 | EIR | Concordia Clinical Research (IRB) - EIR, 2003-06-24 |
| February, 2003 | FDA 483 | Hoffmann La Roche Inc - Form 483, 2003-02-21 |
| April, 2003 | EIR | Bentley Laboratories, LLC - EIR, 2003-04-02 |
| June, 2005 | EIR | Lycored Corp. - EIR, 2005-06-08 |
| August, 2003 | EIR | Actavis Elizabeth LLC - EIR, 2003-08-14 |
| June, 2001 | FDA 483 | Community Blood Council of New Jersey, Inc. - Form 483, 2001-06-26 |
| September, 2002 | EIR | Blispak, Inc. - EIR, 2002-09-20 |
| May, 2003 | EIR | J. Knipper and Company, Inc. - EIR, 2003-05-19 |
| February, 2003 | EIR | Hoffmann La Roche Inc - EIR, 2003-02-21 |
| June, 2001 | FDA 483 Response | Community Blood Council of New Jersey, Inc. - Form 483R, 2001-07-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more